𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Brain injury in the premature infant: Neuropathology, clinical aspects, and pathogenesis

✍ Scribed by Volpe, Joseph J.


Publisher
John Wiley and Sons
Year
1997
Tongue
English
Weight
382 KB
Volume
3
Category
Article
ISSN
1080-4013

No coin nor oath required. For personal study only.

✦ Synopsis


Brain injury in the premature infant is an extremely important problem, in part because of the large absolute number of infants affected yearly. The two principal brain lesions that underlie the neurologic manifestations subsequently observed in premature infants are periventricular hemorrhagic infarction and periventricular leukomalacia. This article emphasizes the neurology, neuropathology, and pathogenesis of these two lesions. Recent work suggests that the ultimate goal, prevention of the lesions, is potentially achievable. Periventricular hemorrhagic infarction may be preventable by prevention of germinal matrix-intraventricular hemorrhage, and periventricular leukomalacia may be preventable by detection of impaired cerebrovascular autoregulation, prevention of impaired cerebral blood flow, and interruption of the cascade to oligodendroglial cell death by such agents as free radical scavengers.


πŸ“œ SIMILAR VOLUMES


Cardiac surgery in the young infant: An
✍ du Plessis, AdrΓ© J. πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 128 KB πŸ‘ 2 views

The remarkable advances in survival of infants with congenital heart disease who undergo cardiac surgery are due in large part to techniques that require periods of markedly decreased or arrested circulation. An obvious prerequisite has been the development of techniques that protect critical organ

IMPACT Recommendations for Improving the
✍ Andrew I.R. Maas; Ewout W. Steyerberg; Anthony Marmarou; Gillian S. McHugh; Hest πŸ“‚ Article πŸ“… 2010 πŸ› Springer-Verlag 🌐 English βš– 83 KB

Clinical trials in traumatic brain injury (TBI) pose complex methodological challenges, largely related to the heterogeneity of the population. The International Mission on Prognosis and Clinical Trial Design in TBI study group has explored approaches for dealing with this heterogeneity with the aim